TAAR1 Activation Modulates Monoaminergic Neurotransmission, Preventing Hyperdopaminergic and Hypoglutamatergic Activity

Total Page:16

File Type:pdf, Size:1020Kb

TAAR1 Activation Modulates Monoaminergic Neurotransmission, Preventing Hyperdopaminergic and Hypoglutamatergic Activity TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Florent G. Revela, Jean-Luc Moreaua, Raul R. Gainetdinovb, Amyaouch Bradaiac, Tatyana D. Sotnikovab, Roland Morya, Sean Durkina, Katrin Groebke Zbindend, Roger Norcrossd, Claas A. Meyere, Veit Metzlera, Sylvie Chaboza, Laurence Ozmena, Gerhard Trubea, Bruno Pouzeta, Bernhard Bettlerf, Marc G. Carong, Joseph G. Wettsteina, and Marius C. Hoenera,1 aNeuroscience Research, dDiscovery Chemistry, and eDiscovery Technologies, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; bDepartment of Neuroscience and Brain Technologies, Italian Institute of Technology, 16163 Genoa, Italy; cNeuroservice, Domaine de Saint-Hilaire, 13593 Aix-en-Provence, France; fDepartment of Biomedicine, Institute of Physiology, Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland; and gDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710 Edited by Richard D. Palmiter, University of Washington, Seattle, WA, and approved March 31, 2011 (received for review February 24, 2011) The trace amine-associated receptor 1 (TAAR1), activated by en- sitive to the locomotor-stimulating effect of d-amphetamine dogenous metabolites of amino acids like the trace amines and show elevated striatal release of dopamine (DA), noradren- p-tyramine and β-phenylethylamine, has proven to be an impor- aline (NA), and serotonin [5-hydroxytryptamine (5-HT)] after a d-amphetamine challenge (10, 12). Furthermore, the spontaneous tant modulator of the dopaminergic system and is considered −/− firing rate of the VTA DA neurons is augmented in Taar1 mice, a promising target for the treatment of neuropsychiatric disorders. fi To decipher the brain functions of TAAR1, a selective TAAR1 ago- and only in WT mice does pTyr decrease this ring rate (10). These fi observations suggest that TAAR1 is a negative modulator of mono- nist, RO5166017, was engineered. RO5166017 showed high af nity aminergic neurotransmission. and potent functional activity at mouse, rat, cynomolgus monkey, Apart from the TAs, TAAR1 is activated by a range of endoge- and human TAAR1 stably expressed in HEK293 cells as well as high nous molecules such as other biogenic amines (2, 5), thyroid selectivity vs. other targets. In mouse brain slices, RO5166017 PHARMACOLOGY hormone-derivative 3-iodothyronamine (T1AM) (13, 14), and inhibited the firing frequency of dopaminergic and serotonergic catechol-O-methyl transferase products (e.g., 3-methoxytyramine) neurons in regions where Taar1 is expressed (i.e., the ventral teg- (2, 15) or by synthetic substances such as amphetamine derivatives mental area and dorsal raphe nucleus, respectively). In contrast, and ergolines (2, 12). However, all these ligands have TAAR1- RO5166017 did not change the firing frequency of noradrenergic independent effects through other targets, such as the mono- neurons in the locus coeruleus, an area devoid of Taar1 expression. aminergic transporters and receptors or the σ-receptors (3, 11, 13, Furthermore, modulation of TAAR1 activity altered the desensiti- 16). The lack of selective ligands has rendered identification of zation rate and agonist potency at 5-HT receptors in the dorsal TAAR1 biological functions challenging. Recently, Bradaia et al. 1A (17) described the first selective TAAR1 antagonist, N-(3-Ethoxy- raphe, suggesting that TAAR1 modulates not only dopaminergic fl but also serotonergic neurotransmission. In WT but not Taar1−/− phenyl)-4-pyrrolidin-1-yl-3-tri uoromethyl-benzamide (EPPTB). Use of EPPTB revealed that TAAR1 tonically activates inwardly mice, RO5166017 prevented stress-induced hyperthermia and rectifying K+ channels in VTA DA neurons to reduce the basal blocked dopamine-dependent hyperlocomotion in cocaine-treated firing activity (17). Importantly, EPPTB increased agonist potency at and dopamine transporter knockout mice as well as hyperactivity DA D2 receptors while reducing their desensitization rate, strongly induced by an NMDA antagonist. These results tie TAAR1 to the suggesting a functional link between TAAR1 and D2 receptors. control of monoamine-driven behaviors and suggest anxiolytic- Further elucidation of TAAR1 physiological functions and and antipsychotic-like properties for agonists such as RO5166017, validation of its promising therapeutic potential require selective opening treatment opportunities for psychiatric disorders. agonists. The ideal characteristics of such molecules are (i) high affinity and intrinsic activity (equal or superior to TAs), (ii) high drug discovery | serotonin | depression | schizophrenia | anxiety selectivity for TAAR1 (in contrast to TAs), (iii) low metabolic turnover (in contrast to TAs), and (iv) favorable pharmacokinetic fi properties, such as a good brain penetration, to enable in vivo n 2001, identi cation of the trace amine-associated receptor fi I1 (TAAR1) provided evidence for a direct biological effect of studies. Here, we report the identi cation of such a compound, so-called trace amines (TAs) (1, 2), a subgroup of biogenic amines RO5166017, which was used for the study of TAAR1 function in previously denoted as false neurotransmitters (3). TAs such as vitro and in vivo. p-tyramine (pTyr), β-phenylethylamine (PEA), octopamine, and tryptamine are metabolites of amino acids with structural simi- larity to classical biogenic amines. Although they are only found Author contributions: F.G.R., J.-L.M., R.R.G., M.G.C., and M.C.H. designed research; F.G.R., at low concentrations in the brain, TAs have been implicated in J.-L.M., R.R.G., A.B., T.D.S., R.M., S.D., K.G.Z., R.N., C.A.M., V.M., S.C., L.O., G.T., and M.C.H. a wide range of neuropathological disorders, including schizo- performed research; K.G.Z. and R.N. contributed new reagents/analytic tools; F.G.R., ’ J.-L.M., R.R.G., A.B., T.D.S., R.M., S.D., C.A.M., V.M., S.C., G.T., B.P., B.B., M.G.C., J.G.W., phrenia, major depression, anxiety states, Parkinson s disease, and M.C.H. analyzed data; and F.G.R., J.-L.M., R.R.G., G.T., and M.C.H. wrote the paper. and attention deficit hyperactivity disorder (3, 4). Conflict of interest statement: F.G.R., J.-L.M., R.M., S.D., K.G.Z., R.N., C.A.M., V.M., S.C., TAAR1, a member of the TAAR family (5, 6), is a G protein- L.O., G.T., B.P., J.G.W., and M.C.H. are F. Hoffmann-La Roche employees. R.R.G. is sup- coupled receptor (GPCR) that signals through Gs to elevate ported in part by research grants from F. Hoffmann-La Roche Ltd. (Basel, Switzerland) and intracellular cAMP levels in response to TAs (6, 7). In vitro Compagnia di San Paolo Fondazione (Turin, Italy). A.B. is employed by Neuroservice. M.G.C. studies have shown a reciprocal regulation between TAAR1 and has received funds for Sponsored Research Agreements unrelated to this work from monoaminergic transporters, particularly the dopamine trans- Forest Laboratories, NeuroSearch, and Lundbeck USA as well as consulting fees from porter (DAT) (8, 9). In the mouse brain, Taar1 is expressed Merck and F. Hoffmann-La Roche Ltd. An unrestricted gift to Duke University was pro- throughout the limbic and monoaminergic systems, including the vided by Lundbeck USA to support Neuroscience research in the laboratory of M.G.C. ventral tegmental area (VTA) and dorsal raphe nucleus (DRN) This article is a PNAS Direct Submission. −/− (10). Mice lacking Taar1 (Taar1 mice) have no overt phenotype 1To whom correspondence should be addressed. E-mail: [email protected]. and appear similar to WT littermates in most neurological and −/− This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. behavioral tests (10–12). However, Taar1 mice are hypersen- 1073/pnas.1103029108/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1103029108 PNAS | May 17, 2011 | vol. 108 | no. 20 | 8485–8490 Downloaded by guest on September 30, 2021 Results Identification of RO5166017 and in Vitro Pharmacological Charac- terization. There seems to be considerable overlap between the pharmacophore space occupied by TAAR1 ligands and ligands of other biogenic amine receptors (2). Therefore, a medicinal chemistry program seeking to create TAAR1 ligands starting from Fig. 1. Chemical structure of the selective TAAR1 agonist RO5166017. adrenergic ligands as a source of lead compounds was started. One of the starting compounds was the amino-oxazoline S18616 (18), α an 2A-adrenergic receptor agonist, and an iterative series of Taar1 fi Because is also expressed in the DRN (10), we asked structural modi cations within this chemical class led to the dis- whether RO5166017 and pTyr also affect the firing frequency covery of RO5166017 [(S)-4-[(ethyl-phenyl-amino)-methyl]-4,5- of 5-HT neurons. Both compounds decreased the spike rate of dihydro-oxazol-2-ylamine] (Fig. 1). DRN 5-HT neurons in WT mice (Fig. 2 C and D and Fig. S3), with fi RO5166017 exhibited high potency and ef cacy at mouse, rat, an IC50 value of 2.99 nM for RO5166017 (Table 1). As in the cynomolgus monkey, and human TAAR1 stably expressed in VTA, the inhibitory effects of pTyr and RO5166017 were blocked HEK293 cells (Table 1). Maximal cAMP levels reached by by EPPTB, which increased the firing frequency over the basal RO5166017 stimulation (maximal efficacy) were in a range similar level. The outward current generated by RO5166017 in the DRN to that achieved by PEA stimulation (set as 100%) at human, rat, was also K+-mediated (Fig. S2 C and D). Finally, neither and monkey TAAR1 (81–95%) and somewhat lower at mouse C D fi RO5166017 (Fig. 2 and ) nor−/− pTyr (Fig. S3) affected the ring TAAR1 (65%). Electrophysiological recordings in Xenopus oocytes rate of 5-HT neurons in Taar1 mice, supporting the specificity as well as VTA and DRN slices resulted in EC50 and IC50 values for of their effects in WT mice. Interestingly, the spontaneous spike mouse TAAR1 (1.7–8 nM) comparable with those obtained by the rate in DRN slices from mutant mice was significantly increased cAMP assay in HEK293 cells (3.3 nM).
Recommended publications
  • The Involvement of Trace Amine-Associated Receptor 1 and Thyroid Hormone Transporters in Non-Classical Pathways of the Thyroid Gland Auto-Regulation
    The Involvement of Trace Amine-Associated Receptor 1 and Thyroid Hormone Transporters in Non-Classical Pathways of the Thyroid Gland Auto-Regulation by Maria Qatato a Thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Cell Biology Approved Dissertation Committee Prof. Dr. Klaudia Brix Jacobs University Bremen Prof. Sebastian Springer, DPhil Jacobs University Bremen Dr. Georg Homuth Ernst-Moritz-Arndt-Universität Greifswald Date of Defence: 16 January 2018 Department of Life Sciences and Chemistry Statutory Declaration Family Name, Given/First Name Qatato, Maria Matriculation number 20330110 What kind of thesis are you submitting: PhD Thesis English: Declaration of Authorship I hereby declare that the thesis submitted was created and written solely by myself without any external support. Any sources, direct or indirect, are marked as such. I am aware of the fact that the contents of the thesis in digital form may be revised with regard to usage of unauthorized aid as well as whether the whole or parts of it may be identified as plagiarism. I do agree my work to be entered into a database for it to be compared with existing sources, where it will remain in order to enable further comparisons with future theses. This does not grant any rights of reproduction and usage, however. This document was neither presented to any other examination board nor has it been published. German: Erklärung der Autorenschaft (Urheberschaft) Ich erkläre hiermit, dass die vorliegende Arbeit ohne fremde Hilfe ausschließlich von mir erstellt und geschrieben worden ist. Jedwede verwendeten Quellen, direkter oder indirekter Art, sind als solche kenntlich gemacht worden.
    [Show full text]
  • Central Effects of Thyronamines on Glucose Metabolism in Rats
    377 Central effects of thyronamines on glucose metabolism in rats Lars P Klieverik1, Ewout Foppen1,3, Marie¨tte T Ackermans2, Mireille J Serlie1, Hans P Sauerwein1, Thomas S Scanlan4, David K Grandy4, Eric Fliers1,* and Andries Kalsbeek1,3,* Laboratory of Endocrinology, Departments of 1Endocrinology and Metabolism and 2Clinical Chemistry, Academic Medical Center, University of Amsterdam, F5-162, 1105 AZ Amsterdam, The Netherlands 3Netherlands Institute for Neuroscience, 1105 AZ Amsterdam, The Netherlands 4Department of Physiology and Pharmacology, School of Medicine, Oregon Health and Science University, Portland, Oregon 97239-3098, USA (Correspondence should be addressed to L P Klieverik; Email: [email protected]) *(E Fliers and A Kalsbeek are joint senior authors) Abstract Thyronamines are naturally occurring, chemical relatives (0.5 mg/kg) thyronamines. Systemic T1AM rapidly increased of thyroid hormone. Systemic administration of synthetic EGP and plasma glucose, increased plasma glucagon, and 3-iodothyronamine (T1AM) and – to a lesser extent – corticosterone, but failed to change plasma insulin. Compared thyronamine (T0AM), leads to acute bradycardia, hypother- with i.p.-administered T1AM, a 100-fold lower dose adminis- mia, decreased metabolic rate, and hyperglycemia. This profile tered centrally induced a more pronounced acute EGP increase led us to hypothesize that the central nervous system is among and hyperglucagonemia while plasma insulin tended to the principal targets of thyronamines. Weinvestigated whether decrease. Both systemic and central infusions of T0AM caused a low dose i.c.v. infusion of synthetic thyronamines recapitu- smaller increases in EGP, plasma glucose, and glucagon lates the changes in glucose metabolism that occur following compared with T1AM. Neither T1AM nor T0AM influenced i.p.
    [Show full text]
  • Design, Synthesis, and Evaluation of Thyronamine Analogues As Novel Potent Mouse Trace Amine Associated Receptor 1
    Article pubs.acs.org/jmc Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists † ‡ ‡ ‡ § Grazia Chiellini,*, Giulia Nesi, Maria Digiacomo, Rossella Malvasi, Stefano Espinoza, † † ∥ ⊥ ‡ Martina Sabatini, Sabina Frascarelli, Annunziatina Laurino, Elena Cichero, Marco Macchia, # ¶ ⊥ ∥ † ‡ Raul R. Gainetdinov, , Paola Fossa, Laura Raimondi, Riccardo Zucchi, and Simona Rapposelli*, † Department of Pathology, University of Pisa, 56100 Pisa, Italy ‡ Deptartment of Pharmacy, University of Pisa, via Bonanno 6, 56100 Pisa, Italy § Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163 Genova, Italy ∥ Department of NEUROFARBA, Section of Pharmacology, University of Florence, 50121 Firenze, Italy ⊥ Department of Pharmacy, University of Genoa, 16126 Genoa, Italy # Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia ¶ Skolkovo Institute of Science and Technology (Skoltech), Skolkovo, Moscow region, 143025, Russia *S Supporting Information ABSTRACT: Trace amine associated receptor 1 (TAAR1) is a G protein coupled receptor (GPCR) expressed in brain and periphery activated by a wide spectrum of agonists that include, but are not limited to, trace amines (TAs), amphetamine-like psychostimulants, and endogenous thyronamines such as thyronamine (T0AM) and 3-iodothyronamine (T1AM). Such polypharmacology has made it challenging to understand the role and the biology of TAAR1. In an effort to understand the molecular basis of TAAR1 activation, we rationally designed and synthesized a small family of thyronamine derivatives. Among them, compounds 2 and 3 appeared to be a good mimic of the parent endogenous thyronamine, T0AM and T1AM, respectively, both in vitro and in vivo. Thus, these compounds offer suitable tools for studying the physiological roles of mouse TAAR1 and could represent the starting point for the development of more potent and selective TAAR1 ligands.
    [Show full text]
  • Chapter 1 Introduction to Thyroid Hormone, Thyronamines, Monoamine
    Copyright 2008 by Aaron Nathan Snead ii Acknowledgments Portions of this work have been published elsewhere. Chapter 2 is adapted with the permission of the American Chemical Society from Snead, A.N., Santos, M.S., Seal, R.P., Edwards, R.H., and Scanlan T.S. (2007) Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem Biol, 2(6), 390-8. Chapter 4 is adapted with permission of Elsevier Ltd. from Snead, A.N., Miyakawa, M., Tan, E.S., and Scanlan T.S. (2008) Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites. Bioorg Med Chem Lett,18(22), 5920-2. Several Compounds tested for activity with rTAAR1,4 and 6 in Chapters 3 and 4 were synthesized by Motonori Miyakawa (Chapter 4, compounds 2, and 4-8) and Edwin S. Tan (Napthylethyamine, and Chapter 4, compounds 3 and 9). We also thank the Amara S. Lab for the donation of the hNET and hDAT DNA constructs, the Blakely R. Lab for the donation of the hSERT DNA construct, and the Grandy D. Lab for the donation of the r-hTAAR1 cell line. This work was supported by fellowship from the Ford Foundation and the NIH Research Supplement to Promote Diversity in Health-Related Research (A.S.), the PEW Latin American Fellowship (M.S.), the NIMH Postdoctoral Fellowship (R.S.), a grant from the NIMH (R.H.E.), and a grant from the National Institutes of Health (T.S.S.). iii Abstract Exploring the Non-Transcriptional Activity of Thyroid Hormone Derivatives This work is premised on the hypothesis that thyroid hormone may be a substrate for the aromatic L-amino acid decarboxylase (AADC) and that the resulting iodothyronamines would have significant structural and perhaps functional similarity with several biogenic amines including the classical monoamine neurotransmitters.
    [Show full text]
  • 3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes
    biology Article 3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes Manuela Gencarelli 1, Annunziatina Laurino 1, Elisa Landucci 2, Daniela Buonvicino 2, Costanza Mazzantini 2, Grazia Chiellini 3 and Laura Raimondi 1,* 1 Department of Neuroscience, Psychology, Drug Sciences, and Child Health (NEUROFARBA), University of Florence, 50139 Florence, Italy; manuela.gencarelli@unifi.it (M.G.); annunziatina.laurino@unifi.it (A.L.) 2 Department of Health Sciences, Section of Pharmacology, University of Florence, 50139 Florence, Italy; elisa.landucci@unifi.it (E.L.); daniela.buonvicino@unifi.it (D.B.); costanza.mazzantini@unifi.it (C.M.) 3 Department of Pathology, University of Pisa, 50123 Pisa, Italy; [email protected] * Correspondence: laura.raimondi@unifi.it; Tel.: +390-554-278-375 Received: 2 April 2020; Accepted: 27 April 2020; Published: 4 May 2020 Abstract: We investigated the effect of 3-iodothyronamine (T1AM) on thermogenic substrates in brown adipocytes (BAs). BAs isolated from the stromal fraction of rat brown adipose tissue were exposed to an adipogenic medium containing insulin in the absence (M) or in the presence of 20 nM T1AM (M+T1AM) for 6 days. At the end of the treatment, the expression of p-PKA/PKA, p-AKT/AKT, p-AMPK/AMPK, p-CREB/CREB, p-P38/P38, type 1 and 3 beta adrenergic receptors (β1–β3AR), GLUT4, type 2 deiodinase (DIO2), and uncoupling protein 1 (UCP-1) were evaluated. The effects of cell conditioning with T1AM on fatty acid mobilization (basal and adrenergic-mediated), glucose uptake (basal and insulin-mediated), and ATP cell content were also analyzed in both cell populations.
    [Show full text]
  • Trace Amines
    Encyclopedia of Psychopharmacology DOI 10.1007/978-3-642-27772-6_211-2 # Springer-Verlag Berlin Heidelberg 2013 Trace Amines Sara Tomlinsona, Darrell D. Mousseaub, Glen B. Bakera* and Ashley D. Radomskia aNeurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry, University of Alberta, Edmonton, AB, Canada bCell Signalling Laboratory, Department of Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada Synonyms Arylalkylamines; Microamines Definition Trace amines, which include b-phenylethylamine (PEA), tryptamine (T), phenylethanolamine (PEOH), tyramines (TAs), octopamines (OAs), and synephrine (SYN) [some authors include N, N-dimethyltryptamine (DMT) in this list], are amines related structurally to, but present in the brain at much lower concentrations than, the classical neurotransmitter amines – dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT, serotonin). Pharmacological Properties History The trace amines are so named because of their low absolute concentrations in the brain compared to the classical neurotransmitter amines DA, NA, and 5-HT; they are very similar structurally to these neurotransmitter amines (often only lacking one or both hydroxyl moeities on the benzene ring: Fig. 1), but have much higher turnover rates, and in contrast to their hydroxylated analogs, PEA and T pass the blood–brain barrier readily. From the 1960s through to the 1990s, there was a great deal of interest in the trace amines in the central nervous system (CNS) as behavioral and pharmacological studies in animals and neuro- chemical measurements in body fluids from human subjects suggested their involvement in the etiology and pharmacotherapy of a number of psychiatric and neurological disorders, including depression, schizophrenia, phenylketonuria (PKU), Reye’s syndrome, Parkinson’s disease, attention deficit hyperactivity disorder (ADHD), Tourette’s syndrome, epilepsy, and migraine headaches (Baker et al.
    [Show full text]
  • Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells
    cells Article Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells Maria Qatato, Vaishnavi Venugopalan † , Alaa Al-Hashimi †, Maren Rehders †, Aaron D. Valentine , Zeynep Hein, Uillred Dallto, Sebastian Springer and Klaudia Brix * Department of Life Sciences and Chemistry, Focus Area HEALTH, Jacobs University Bremen, Campus Ring 1, D-28759 Bremen, Germany; [email protected] (M.Q.); [email protected] (V.V.); [email protected] (A.A.-H.); [email protected] (M.R.); [email protected] (A.D.V.); [email protected] (Z.H.); [email protected] (U.D.); [email protected] (S.S.) * Correspondence: [email protected]; Tel.: +49-421-200-3246 † These authors contributed equally to this study. Abstract: Trace amine-associated receptor 1 (rodent Taar1/human TAAR1) is a G protein-coupled receptor that is mainly recognized for its functions in neuromodulation. Previous in vitro studies suggested that Taar1 may signal from intracellular compartments. However, we have shown Taar1 to localize apically and on ciliary extensions in rodent thyrocytes, suggesting that at least in the thyroid, Taar1 may signal from the cilia at the apical plasma membrane domain of thyrocytes in situ, where it is exposed to the content of the follicle lumen containing putative Taar1 ligands. This study was designed to explore mouse Taar1 (mTaar1) trafficking, heterologously expressed in human and rat thyroid cell lines in order to establish an in vitro system in which Taar1 signaling from the cell Citation: Qatato, M.; Venugopalan, surface can be studied in future.
    [Show full text]
  • UC San Francisco Electronic Theses and Dissertations
    UCSF UC San Francisco Electronic Theses and Dissertations Title Understanding the Molecular Basis of Trace Amine-Associated Receptor 1 Activation by Thyronamines and Related Analogs Permalink https://escholarship.org/uc/item/8746b5s5 Author Tan, Edwin Saavedra Publication Date 2007-12-21 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UMI Number: 3289321 UMI Microform 3289321 Copyright 2008 by ProQuest Information and Learning Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. ProQuest Information and Learning Company 300 North Zeeb Road P.O. Box 1346 Ann Arbor, MI 48106-1346 Copyright 2007 by Edwin Saavedra Tan ii Acknowledgements I dedicate this dissertation to my parents, Ismael and Thelma, and my siblings, Irene, Samuel, Annabel and Richard for their unwavering love, support, and encouragement. My parents have taught me the value of a good education and work ethic, being resourceful, and performing to the best of my abilities. They have been by my side throughout my life and have helped me through the tough times and celebrate accomplishments. I am thankful for the sacrifices they have made to give me and my siblings the opportunity to pursue a career that we are passionate about. I want to thank my brothers and sisters for being available when I wanted to get away from work and for listening to me when I needed to talk. I would like to thank my research advisor, Thomas Scanlan, for being an excellent mentor. His advice, guidance, and expertise have been invaluable throughout my graduate career.
    [Show full text]
  • How Reliable Is the Electrochemical Readout of MIP Sensors?
    sensors Review How Reliable Is the Electrochemical Readout of MIP Sensors? Aysu Yarman * and Frieder W. Scheller * Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Strasse 24-25, 14476 Potsdam, Germany * Correspondence: [email protected] (A.Y.); [email protected] (F.W.S.) Received: 14 April 2020; Accepted: 6 May 2020; Published: 8 May 2020 Abstract: Electrochemical methods offer the simple characterization of the synthesis of molecularly imprinted polymers (MIPs) and the readouts of target binding. The binding of electroinactive analytes can be detected indirectly by their modulating effect on the diffusional permeability of a redox marker through thin MIP films. However, this process generates an overall signal, which may include nonspecific interactions with the nonimprinted surface and adsorption at the electrode surface in addition to (specific) binding to the cavities. Redox-active low-molecular-weight targets and metalloproteins enable a more specific direct quantification of their binding to MIPs by measuring the faradaic current. The in situ characterization of enzymes, MIP-based mimics of redox enzymes or enzyme-labeled targets, is based on the indication of an electroactive product. This approach allows the determination of both the activity of the bio(mimetic) catalyst and of the substrate concentration. Keywords: molecularly imprinted polymers; electropolymerization; direct electron transfer; catalysis; redox marker; gate effect 1. Introduction Over the past decades, increasing attention has been paid to the fast, selective and cost-effective detection and determination of analytes in many areas, including clinical diagnostics, pharmaceutical and environmental analysis, food control and security. Well-established laboratory-based (bio)analytical methods achieved great breakthroughs due to the highly specific interactions involved in most biological processes, e.g., the antigen–antibody interaction, substrate conversion by the action of enzymes and the sequence-specific hybridization of nucleic acids [1].
    [Show full text]
  • Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Aversion
    TITLE AND INDEX TRACE AMINE-ASSOCIATED RECEPTOR 1 REGULATION OF METHAMPHETAMINE INTAKE AND AVERSION By JOHN H. HARKNESS A DISSERTATION Presented to the Department of Behavioral Neuroscience and the Oregon Health & Science University School of Medicine in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy September 2015 TABLE OF CONTENTS LIST OF FIGURES v LIST OF TABLES vii LIST OF ABBREVIATIONS viii ACKNOWLEDGEMENTS xiii ABSTRACT xv CHAPTER 1: General Introduction 1 History of Methamphetamine Use 1 Methamphetamine as a Drug of Abuse 1 Impact on Health and Communities 4 Current Therapies for Methamphetamine Abuse 5 Pharmacology of Methamphetamine 8 Pharmacokinetics 9 Absorption and Distribution 9 Metabolism and Excretion 11 Pharmacodynamics 12 Actions at Monoamine transporters 12 Trace Amine-Associated Receptor 1 (TAAR1) 13 Factors Mediating Methamphetamine Addiction 18 Adaptations to the Basal Ganglia Reward Pathway 18 Positive and Negative Subjective Effects of 20 Methamphetamine i Physiological Effects 22 Stress Axis Activation 22 Thermal Effects 24 Genetic Influences in Drug Use Behavior 25 Forward and Reverse Genetic Approaches 26 Quantitative Traits 28 QTL Mapping Populations 31 Crosses Derived from Inbred Strains 31 Selective Bred Lines 34 The High and Low MA Drinking (MADR) 39 Selected Lines Methods to Study Drug Effects in Animals 41 Two-Bottle Choice Drinking 42 Self-Administration 45 Conditioned Place Preference and Place 46 Aversion Conditioned Taste Aversion 50 QTL Mapping and Gene Expression Analysis
    [Show full text]
  • Normal Thermoregulatory Responses to 3-Iodothyronamine, Trace Amines and Amphetamine-Like Psychostimulants in Trace Amine Associated Receptor 1 Knockout Mice
    Journal of Neuroscience Research 88:1962–1969 (2010) Normal Thermoregulatory Responses to 3-iodothyronamine, Trace Amines and Amphetamine-like Psychostimulants in Trace Amine Associated Receptor 1 Knockout Mice Helen N. Panas,1 Laurie J. Lynch,1 Eric J. Vallender,1 Zhihua Xie,1 Guo-lin Chen,1 Spencer K. Lynn,2 Thomas S. Scanlan,3 and Gregory M. Miller1* 1Division of Neuroscience, Harvard Medical School/NEPRC, Southborough, Massachusetts 2Molecular Pharmacology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts and Interdisciplinary Affective Science Laboratory, Department of Psychology, Boston College, Chestnut Hill, Massachusetts 3Department of Physiology & Pharmacology, Oregon Health and Science University, Portland, Oregon 3-Iodothyronamine (T1AM) is a metabolite of thyroid hor- 3-Iodothyronamine (T1AM) is an endogenous de- mone. It is an agonist at trace amine-associated receptor rivative of thyroid hormone and itself a possible chemi- 1 (TAAR1), a recently identified receptor involved in mono- cal messenger (Scanlan et al., 2004). In various studies in aminergic regulation and a potential novel therapeutic tar- which the biological response to T1AM has been meas- get. Here, T1AM was studied using rhesus monkey ured, changes in temperature, heart rate and cardiac out- TAAR1 and/or human dopamine transporter (DAT) co- put have been observed. Most strikingly, T1AM pro- transfected cells, and wild-type (WT) and TAAR1 knock- duces a profound hypothermic response when adminis- out (KO) mice. The IC50 of T1AM competition for binding tered in vivo (Scanlan et al., 2004). The robust of the DAT-specific radio-ligand [3H]CFT was highly similar hypothermic action of T1AM suggests that the thyron- in DAT cells, WT striatal synaptosomes and KO striatal amine could serve as a neuroprotectant, and that its re- synaptosomes (0.72–0.81 lM).
    [Show full text]
  • Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1
    0022-3565/07/3201-475–485$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 320, No. 1 Copyright © 2007 by The American Society for Pharmacology and Experimental Therapeutics 112532/3163227 JPET 320:475–485, 2007 Printed in U.S.A. Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1 David B. Wainscott, Sheila P. Little, Tinggui Yin, Yuan Tu, Vincent P. Rocco, John X. He, and David L. Nelson Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana Received August 21, 2006; accepted October 11, 2006 Downloaded from ABSTRACT The hemagglutinin-tagged human trace amine-associated re- having potencies as good as or better than ␤-PEA. A number of ␣ ceptor1 (TAAR1) was stably coexpressed with rat G s in the nonselective antagonists known to share affinity for multiple AV12-664 cell line, and receptor activation was measured as monoaminergic receptors were evaluated for their ability to the stimulation of cAMP formation. After blockade of endog- inhibit ␤-PEA stimulation of the human TAAR1. None had an ␣ ␤ Ͻ ␮ jpet.aspetjournals.org enously expressed 2- and -adrenoceptors with 2-[2-(2- IC50 10 M. For comparison, the rat TAAR1 receptor was methoxy-1,4-benzodioxanyl)]-imidazoline hydrochloride (2- expressed in the AV12-664 cell line. A number of agonist com- methoxyidazoxan, RX821002) and alprenolol, respectively, the pounds had significantly different relative potencies between resulting pharmacology was consistent with that of a unique the rat and human TAAR1, demonstrating a significant species receptor subtype. ␤-Phenylethylamine (␤-PEA), the putative en- difference between the rat and human TAAR1.
    [Show full text]